Washington, DC — www.cbinet.com
Mitigate Risk. Increase Compliance.
The device and diagnostics industry is in the spotlight of regulators and enforcement agencies to ensure that interactions with HCPs in the U.S. and abroad are compliant. More device and diagnostics companies are under investigation and settling with the government each month as the enforcement community shifts their attention from pharmaceutical manufacturers. With the increased risk of individual liability as well as corporate liability, companies must improve compliance processes and strategies to meet the new standards of a truly effective corporate compliance program.
Top Reasons to Attend: